Eagle Asset Management Inc Raises Its Position in NxStage Medical, Inc. (NXTM)

Paterniano Del Favero
Agosto 12, 2017

Quantitative Systematic Strategies LLC bought a new stake in shares of NxStage Medical during the second quarter valued at about $203,000. NxStage Medical had a negative net margin of 1.33% and a negative return on equity of 2.46%. It closed at $29.32 lastly. It has outperformed by 4.48% the S&P500. Swan now owns $320,603 of stock per an SEC filing yesterday. Following moving averages with different time frames may help offer a wide variety of stock information. The value of the investment in (NXTM) increased from $3,188,000 to $3,206,000 a change of 0.6% since the last quarter. It is down 43.12% since August 9, 2016 and is uptrending. It has outperformed by 102.55% the S&P500.

Investors sentiment decreased to 0.85 in Q4 2016.

Several other large investors have also modified their holdings of the company. Adams Diversified Equity Fund, Maryland-based fund reported 39,900 shares. Mufg Americas Holdg holds 105 shares. Geode Cap Management Ltd owns 0% invested in MOCON, Inc. Company has far performed well this year, with the share price up 11.71% since January. M&T Bank holds 0.01% of its portfolio in DISH Network Corp (NASDAQ:DISH) for 23,893 shares. (NASDAQ:NXTM). Tiverton Asset Mngmt Limited Co stated it has 147,656 shares or 0.23% of all its holdings. Pub Employees Retirement Association Of Colorado has invested 0.02% in DISH Network Corp (NASDAQ:DISH). Crawford Counsel invested in 0.09% or 128,425 shares.

Among 19 analysts covering Dish Network Corp. The stock has "Hold" rating by Northland Capital on Monday, August 7. Therefore 38% are positive.

A number of equities research analysts have weighed in on NXTM shares. BTIG Research has "Buy" rating and $2700 target. The rating was downgraded by Wunderlich to "Sell" on Friday, July 22.

On 08/10/2017 McDonald's Corporation (NYSE:MCD) stock surged 1.10% to finish at $156.62. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the company. The company's market cap is $1.93 billion. Goldman Sachs maintained it with "Buy" rating and $83 target in Thursday, April 21 report. Canaccord Genuity downgraded the shares of NXTM in report on Monday, August 7 to "Hold" rating. 6 of them rate its stock a hold. The rating was maintained by Northland Capital on Monday, August 7 with "Hold". (NASDAQ:NXTM) rating on Tuesday, June 6. Russell Investments Group Ltd. raised its position in shares of NxStage Medical by 67.9% in the first quarter. (NASDAQ:NXTM). Whittier Tru owns 2,250 shares. Ethan Allen Interiors Inc Com (NYSE:ETH) was reduced too. Insiders sold 53,900 shares of company stock valued at $1,404,073 over the last 90 days. (NASDAQ:CHTR), its shares were trading at $389.75 a gain of $8.73, on the trading floor. Brown Robert S. sold $69,229 worth of stock. TRANSAT AT Inc (TSE:TRZ) has 0.00% since August 10, 2016 and is. Its down 0.05, from 1.18 in 2016Q3. (NYSE:PFE). Ifc Fl invested 0.22% of its portfolio in Pfizer Inc. Susquehanna Group Limited Liability Partnership holds 0% or 113,269 shares. 500 were accumulated by Barnett & Co. Suntrust Banks stated it has 9,271 shares. NxStage Medical, Inc. has a 12-month low of $20.45 and a 12-month high of $30.80. Institutional investors and hedge funds own 91.11% of the company's stock. (NASDAQ:NXTM) on Wednesday, May 3. Tiaa Cref Investment Management LLC now owns 215,788 shares valued at $5,410,000. Blackrock Fund Advsrs has 2.08 million shares.

William Blair cut shares of NxStage Medical, Inc.

Eagle Asset Management Inc isn't the only one who has changed their investment in NXTM. Of the analysts surveyed by Reuters that track Nxstage Medical, Inc.

NxStage Medical (NASDAQ:NXTM) opened at 29.28 on Monday. (NASDAQ:MOCO) for 13,177 shares. (NASDAQ:MOCO) for 952 shares.

Since February 27, 2017, it had 0 buys, and 5 insider sales for $5.16 million activity.

On the other hand the company has Relative Strength Index (RSI 14) of 77.2 along with Average True Range (ATR 14) of 0.98, Consequently Nxstage Medical Inc (NASDAQ:NXTM)'s weekly and monthly volatility is 1.61%, 2.30% respectively. Market capitalization is the total value of any firm in the stock market. $125,818 worth of stock was sold by TOWSE MATTHEW W on Tuesday, February 21.

Altre relazioni OverNewsmagazine

Discuti questo articolo